CARULLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 13.520
EU - Europa 8.271
AS - Asia 6.806
SA - Sud America 813
AF - Africa 137
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 29.574
Nazione #
US - Stati Uniti d'America 13.372
SE - Svezia 2.337
SG - Singapore 2.204
CN - Cina 2.044
GB - Regno Unito 1.832
IT - Italia 1.764
HK - Hong Kong 818
DE - Germania 655
VN - Vietnam 608
BR - Brasile 596
FI - Finlandia 377
UA - Ucraina 330
TR - Turchia 318
FR - Francia 302
RU - Federazione Russa 241
KR - Corea 198
IN - India 139
BG - Bulgaria 124
AR - Argentina 85
BD - Bangladesh 84
NL - Olanda 61
CA - Canada 60
IQ - Iraq 52
ID - Indonesia 51
MX - Messico 50
JP - Giappone 45
ZA - Sudafrica 38
IE - Irlanda 35
AE - Emirati Arabi Uniti 34
PL - Polonia 30
CH - Svizzera 29
VE - Venezuela 28
EC - Ecuador 25
ES - Italia 25
CO - Colombia 24
TW - Taiwan 24
CZ - Repubblica Ceca 22
MY - Malesia 21
BE - Belgio 20
CL - Cile 19
MA - Marocco 19
PH - Filippine 19
PK - Pakistan 19
UZ - Uzbekistan 19
AT - Austria 15
EG - Egitto 14
KE - Kenya 14
SA - Arabia Saudita 14
CR - Costa Rica 12
PT - Portogallo 12
AU - Australia 11
JO - Giordania 11
PE - Perù 11
PY - Paraguay 11
AZ - Azerbaigian 10
NP - Nepal 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
RO - Romania 9
BO - Bolivia 8
EU - Europa 8
ET - Etiopia 7
LT - Lituania 7
TN - Tunisia 7
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
BH - Bahrain 5
LU - Lussemburgo 5
SI - Slovenia 5
UY - Uruguay 5
AL - Albania 4
GE - Georgia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
UG - Uganda 4
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
CY - Cipro 2
GA - Gabon 2
GH - Ghana 2
GR - Grecia 2
JM - Giamaica 2
KH - Cambogia 2
MD - Moldavia 2
PS - Palestinian Territory 2
Totale 29.545
Città #
Stockholm 1.787
Singapore 1.492
Santa Clara 1.256
Southend 1.147
Ashburn 1.043
Fairfield 1.030
Hong Kong 805
Woodbridge 789
Jacksonville 725
Chandler 721
Hefei 689
Houston 617
San Jose 529
Dearborn 492
Ann Arbor 469
Chicago 375
Seattle 375
Wilmington 375
Beijing 368
Cambridge 359
Nyköping 346
London 300
Los Angeles 289
Helsinki 229
The Dalles 209
Ho Chi Minh City 189
Seoul 185
Izmir 182
Hanoi 157
New York 149
Milan 146
Salt Lake City 144
Princeton 127
Modena 123
San Diego 123
Sofia 120
Eugene 115
Des Moines 111
Munich 103
Lauterbourg 96
Shanghai 93
Rome 92
Tampa 87
Grafing 73
Council Bluffs 71
Elk Grove Village 71
Buffalo 70
Moscow 69
Dallas 63
São Paulo 60
Columbus 56
Orem 49
Bremen 48
Bologna 46
Falls Church 46
Sterling 37
Boardman 34
Guangzhou 33
Turin 33
Dublin 32
Naples 32
Bari 31
Tokyo 31
Turku 30
Baghdad 29
Kunming 29
Lancaster 27
Napoli 27
Frankfurt am Main 26
Da Nang 25
Kent 25
Redwood City 25
Chennai 24
Warsaw 24
Brooklyn 23
Florence 22
Jakarta 22
Miami 22
Torino 22
Haiphong 21
Phoenix 21
Palermo 20
San Mateo 20
Atlanta 19
Brno 19
Mexico City 19
Nanjing 19
Amsterdam 18
Brussels 18
Rio de Janeiro 18
Parma 17
Verona 17
Falkenstein 16
Montreal 16
Zhengzhou 16
Catania 15
Sondrio 15
Dhaka 14
Fremont 14
Norwalk 14
Totale 20.911
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.047
Le basi scientifiche dell'approccio bio-psico-sociale. Indicazioni per l'acquisizione delle competenze mediche appropriate 1.607
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 445
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 411
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 408
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 405
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 395
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 394
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 375
Review article: diabetes, genetics and ethnicity 366
Characteristics of patients in a ward of Academic Internal Medicine. Implications for medical care, training programs and research 346
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 345
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 334
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 329
Growth of human herpesvirus 6 in HepG2 cells 323
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 319
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 308
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 304
Factors associated with gallstone disease in the MICOL experience 302
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 293
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 293
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 290
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 286
Advances in the comprehension of the pathophysiology of bile secretion 284
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 282
Chicken or egg turned into head or belly 279
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 278
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 276
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 271
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 271
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 269
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 264
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 260
Effects of acute changes of bile acid pool composition on biliary lipid secretion 258
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 256
Bile acid structure and regulation of biliary protein secretion and composition in man 255
Effect of ursocholic acid on bile lipid secretion and composition 252
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 251
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 250
Growth hormone plasma levels in nonalcoholic fatty liver disease 248
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 245
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 245
Influence of age and sex on serum concentrations of total dimeric activin A 242
Review article: hyperlipidaemia and cardiovascular risk 236
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 235
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 234
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 232
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 232
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 232
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 231
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 227
Bile acid and hepatocyte death 226
Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel 224
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 223
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 222
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 215
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 215
Statins and HCV: a complex issue 214
Regolazione della sintesi di colesterolo e acidi biliari 213
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 213
Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans 207
Dysmetabolic changes associated with HCV: a distinct syndrome? 207
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 205
HCV and diabetes. A two-question-based reappraisal. 201
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 201
Cirrosi criptogenetiche. Un report di 5 pazienti 199
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. 194
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 193
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 192
Fatty liver, carotid disease and gallstones: A study ofage-related associations 191
Reply 189
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 188
EFFECT OF FISH OIL AND COCONUT OIL DIET ON THE LDL RECEPTOR ACTIVITY OF RAT LIVER PLASMA MEMBRANES. 188
Acute abdomen associated with schistosomiasis of the appendix 188
Prevalence rates of gallstone disease in Italy: the Chianciano population study 187
Chronic hepatopathies: from cryptogenetics to multiple factors 184
Cholestatic icterus: is there still a role for the clinic? 184
Patogenesi della colelitiasi 182
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 182
Hepatitis C and steatosis: a reappraisal 182
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man 181
Colelitiasi sintomatica: affiorano dubbi sulla necessita' dell'intervento. 180
Ursodeoxycholic acid improves liver tests in chronic hepatitis - Results of a randomised controlled trial 177
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies 176
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 175
Patogenesi ed epidemiologia della steatosi epatica e della steatoepatite non alcolica (NASH). 171
Nuove prospettive terapeutiche con acidi biliari. 170
Should nonalcoholic fatty liver disease be renamed? 169
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 169
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 168
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 167
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 166
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 165
Risk for cardiovascular events in a local population of diabetic patients 164
Gallstone dissolution. 163
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 162
Dietary cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. 161
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 160
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 158
Bile acids and cholesterol metabolism: Effect of deoxycholic acid on plasma lipoprotein and biliary cholesterol concentration 158
Totale 27.189
Categoria #
all - tutte 104.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 0 0 0 0 156 91
2021/20222.156 70 273 194 200 54 114 155 118 229 125 365 259
2022/20232.135 235 218 135 210 241 379 59 185 270 31 89 83
2023/20241.387 72 68 66 108 267 131 182 178 45 49 84 137
2024/20254.750 181 92 104 315 988 599 381 219 442 176 550 703
2025/202610.616 514 441 706 1.119 2.023 735 1.139 377 2.575 804 183 0
Totale 29.643